Back to results
US 2026/0102406 A1Published application
Substituted quinazolines for inhibiting kinase activity
AssigneeNeupharma, Inc.
InventorsXiangping QIAN, Yong-Liang ZHU
Life of this patent
Estimating the term…
Abstract
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
Claims22
-97. (canceled)
A compound or pharmaceutically acceptable salt thereof, wherein the compound is N-(3-(2-((2,3-difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide having the structure
Dependencies are inferred from the claim text.